Gene Salkind Net Worth

The estimated Net Worth of Gene Salkind is at least $0 dollars as of 31 December 2019. Gene Salkind owns over 7,593 units of DermTech stock worth over $0 and over the last 5 years Gene sold DMTKW stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Gene Salkind DMTKW stock SEC Form 4 insiders trading

Gene has made over 1 trades of the DermTech stock since 2019, according to the Form 4 filled with the SEC. Most recently Gene exercised 7,593 units of DMTKW stock worth $0 on 31 December 2019.

The largest trade Gene's ever made was exercising 7,593 units of DermTech stock on 31 December 2019 worth over $0. On average, Gene trades about 3,797 units every 0 days since 2019. As of 31 December 2019 Gene still owns at least 173,154 units of DermTech stock.

You can see the complete history of Gene Salkind stock trades at the bottom of the page.

What's Gene Salkind's mailing address?

Gene's mailing address filed with the SEC is C/O DERMTECH, INC., 11099 N. TORREY PINES RD. SUITE 100, SAN DIEGO, CA, 92037.

Insiders trading at DermTech

Over the last 6 years, insiders at DermTech have traded over $19,870,889 worth of DermTech stock and bought 582,885 units worth $10,695,697 . The most active insiders traders include Investments, Lpwong Roderic..., Mark Christopher Capone, and Herm Rosenman. On average, DermTech executives and independent directors trade stock every 15 days with the average trade being worth of $0. The most recent stock trade was executed by Kevin M Sun on 7 December 2023, trading 5,426 units of DMTKW stock currently worth $8,248.

What does DermTech do?

Complete history of Gene Salkind stock trades at DermTech

DermTech executives and stock owners

DermTech executives and other stock owners filed with the SEC include:

• Scott R Pancoast,
  Director
• Gary E. Jacobs,
  Director
• Enrico Picozza,
  Director
• Investments, Lpwong Roderic...,
  
• Inc.Cowen Investments Ii Ll...,
  
• Cynthia Collins,
  Director
• John Dobak,
  Chief Executive Officer
• Zuxu Yao,
  Chief Scientific Officer
• & Joan Jacobs Trust Dated 6...,
  
• Matthew L. Posard,
  Director
• Burkhard Jansen,
  Chief Medical Officer
• Herm Rosenman,
  Director
• Gene Salkind,
  Director
• Todd Michael Wood,
  Chief Commercial Officer
• Claudia Ibarra,
  Chief Operating Officer
• Ramin Akhavan,
  General Counsel
• Kevin M Sun,
  Chief Financial Officer
• Mark Christopher Capone,
  Director
• Monica Tellado,
  Director
• Kirk Malloy,
  Director
• Nathalie Gerschtein Keraudy,
  Director
• Mark Bryan Aguillard,
  Chief Commercial Officer
• Bret Christensen,
  Chief Executive Officer